Mortality is not increased in SARS‐CoV‐2 infected persons with hepatitis C virus infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mortality is not increased in SARS‐CoV‐2 infected persons with hepatitis C virus infection
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-05
DOI
10.1111/liv.14804
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study
- (2020) Adeel Ajwad Butt et al. JOURNAL OF HEPATOLOGY
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal complications in COVID-19: a systematic review and meta-analysis
- (2020) Setor K. Kunutsor et al. ANNALS OF MEDICINE
- Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis
- (2020) Yanyan Wu et al. Hepatology International
- High rates of 30-day mortality in patients with cirrhosis and COVID-19
- (2020) Massimo Iavarone et al. JOURNAL OF HEPATOLOGY
- Neurological comorbidity and severity of COVID-19
- (2020) Alberto Romagnolo et al. JOURNAL OF NEUROLOGY
- Neurological manifestations in 404 COVID-19 patients in Washington State
- (2020) Pinky Agarwal et al. JOURNAL OF NEUROLOGY
- New-Onset Diabetes in Covid-19
- (2020) Francesco Rubino et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)
- (2020) Valentina O. Puntmann et al. JAMA Cardiology
- Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis
- (2020) Bryony Simmons et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rates and characteristics of SARS‐CoV‐2 infection in persons with hepatitis C virus infection
- (2020) Adeel A. Butt et al. LIVER INTERNATIONAL
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
- (2020) Lifeng Fu et al. Nature Communications
- The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study
- (2018) Darrick K. Li et al. HEPATOLOGY
- Direct-acting Antiviral Therapy for HCV Infection is Associated with a Reduced Risk of Cardiovascular Disease Events
- (2018) Adeel A. Butt et al. GASTROENTEROLOGY
- Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
- (2016) Tracey G. Simon et al. HEPATOLOGY
- Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES
- (2015) Shari S. Rogal et al. DIGESTIVE DISEASES AND SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now